Details about the neuroanatomical projections from ORBvl to TEv
To view more data and metadata associated with each report, click on its ID.
| Report ID | Sending structure | Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
|---|---|---|---|---|---|---|---|
| 91804 | Orbital area ventrolateral part | Ventral temporal association areas | moderate | biotinylated dextran amine (BDA) | Collator note: terminal field in layer II, with some extension in layer V. See Fig. 5E, Swanson Atlas Levels 45-46. | Kondo H. & Witter M.P., 2014 | |
| 91806 | Orbital area ventrolateral part | Ventral temporal association areas | strong | biotinylated dextran amine (BDA) | Collator note: dense labeling in the caudalmost part of both ECT and TEA, in layers II-III. See Fig. 5F, Swanson Atlas Levels 46-47. | Kondo H. & Witter M.P., 2014 | |
| 91823 | Orbital area ventrolateral part | Ventral temporal association areas | light | biotinylated dextran amine (BDA) | Collator note: few terminals in the rostral TEA. See Fig. 6A-D, Swanson Atlas Levels 30-42. | Kondo H. & Witter M.P., 2014 |
| General description technique/protocol: In a representative case (case F-17), the BDA injection targeted the lateral portion of VO at a caudal level (Figs. 2, 5). The injection involved mainly layers II and III.Collator note: injection in the caudal third of the ORBvl. See Figs. 1, 2, and 5. The injection is mapped here onto Swanson Atlas Levels 5-6. |
Further details associated to record number 91806:
|
|
|---|
